Notably, addition of CCL2 induced both CCL22 and CCR4 expression in prostate cancer cells; CCL22 subsequently promoted the migration and invasion of prostate cancer cells in an autocrine manner, via enhanced phosphorylation of Akt [11]. Here, CCL22 is linked to prostate carcinoma.